Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Hill

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
One Health Outlook|April 5, 2022
A community-based survey to assess risk for one health challenges in rural Philippines using a mobile applicationTae Youn Kim, Loinda Baldrias, Sophia Papageorgiou, et al.
Vaccine|April 16, 2009
Small protective fragments of the Yersinia pestis V antigenClaire Vernazza, Bry Lingard, Helen C Flick-Smith, et al.
Microbes and Infection|June 9, 2007
The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestisDagmar Reithmeier-Rost, Jim Hill, Stephen J Elvin, et al.
Journal of Microbiological Methods|July 22, 2006
Identification of outer membrane proteins of Yersinia pestis through biotinylationSophie J Smither, Jim Hill, Ben L M van Baar, et al.
The Journal of Biological Chemistry|July 11, 2002
Interactions of the type III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil domainsDaniel G Lawton, Colin Longstaff, B A Wallace, et al.
Vaccine|October 18, 2008
Antibodies and cytokines independently protect against pneumonic plagueLawrence W Kummer, Frank M Szaba, Michelle A Parent, et al.
European Journal of Clinical Nutrition|August 27, 2024
Healthy Eating and Active Lifestyle after Bowel Cancer (HEAL ABC)-feasibility randomised controlled trialJana Sremanakova, Anne Marie Sowerbutts, Chris Todd, et al.
Vaccine|September 16, 2010
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plagueJr-Shiuan Lin, Steven Park, Jeffrey J Adamovicz, et al.
Vaccine|September 30, 2009
N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infectionJim Hill, Sophie Leary, Sophie Smither, et al.
Microbiology (Reading, England)|August 4, 2004
Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosisMark P Stevens, Ashraful Haque, Timothy Atkins, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
One Health Outlook|April 5, 2022
A community-based survey to assess risk for one health challenges in rural Philippines using a mobile applicationTae Youn Kim, Loinda Baldrias, Sophia Papageorgiou, et al.
Vaccine|April 16, 2009
Small protective fragments of the Yersinia pestis V antigenClaire Vernazza, Bry Lingard, Helen C Flick-Smith, et al.
Microbes and Infection|June 9, 2007
The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestisDagmar Reithmeier-Rost, Jim Hill, Stephen J Elvin, et al.
Journal of Microbiological Methods|July 22, 2006
Identification of outer membrane proteins of Yersinia pestis through biotinylationSophie J Smither, Jim Hill, Ben L M van Baar, et al.
The Journal of Biological Chemistry|July 11, 2002
Interactions of the type III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil domainsDaniel G Lawton, Colin Longstaff, B A Wallace, et al.
Vaccine|October 18, 2008
Antibodies and cytokines independently protect against pneumonic plagueLawrence W Kummer, Frank M Szaba, Michelle A Parent, et al.
European Journal of Clinical Nutrition|August 27, 2024
Healthy Eating and Active Lifestyle after Bowel Cancer (HEAL ABC)-feasibility randomised controlled trialJana Sremanakova, Anne Marie Sowerbutts, Chris Todd, et al.
Vaccine|September 16, 2010
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plagueJr-Shiuan Lin, Steven Park, Jeffrey J Adamovicz, et al.
Vaccine|September 30, 2009
N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infectionJim Hill, Sophie Leary, Sophie Smither, et al.
Microbiology (Reading, England)|August 4, 2004
Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosisMark P Stevens, Ashraful Haque, Timothy Atkins, et al.
Pageof 3